Clinical Trials in Pennsylvania

Showing 12141-12160 of 19,675 trials

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

NCT01945424

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on vaccine exposures, pregnancy outcomes, and fetal and offspring outcomes.

PregnancyInfluenza

Sanofi Pasteur, a Sanofi Company244 participantsStarted Aug 2013

San Diego, California, United States • Albany, New York, United States • Columbus, Ohio, United States +2 more locations

COMPLETEDPhase 328 miles

Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

NCT01298219

The primary purpose of the study is to evaluate the efficacy and safety of lubiprostone administration in subjects with Opioid-induced Bowel Dysfunction.

Opioid-induced Bowel Dysfunction

Sucampo Pharma Americas, LLC439 participantsStarted Dec 2010

Athens, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +139 more locations

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)

Find Trials by Condition in Pennsylvania

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults

A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma

The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA)

A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)

Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System

A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants

First-in-Human Study of MS201408-0005A as Single Agent and in Combinations

Assessment of Ventilatory Management During General Anesthesia for Robotic Surgery

Study of Safety and Effectiveness of PoNS Device to Treat Chronic Balance Deficit Due to Traumatic Brain Injury (TBI)

A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State